- Home
- Equipment
- switzerland
- hematology
Refine by
Hematology Equipment Supplied In Switzerland
16 equipment items found
Manufactured by:Beckman Coulter, Inc. based inBrea, CALIFORNIA (USA)
The first in a new series of Hematology analyzers, the DxH 500 was specifically designed for physician offices and other laboratories with low-volume workloads. The system allows you to improve laboratory efficiency and reduce operating costs — saving you time and money while delivering high-quality ...
Manufactured by:Beckman Coulter, Inc. based inBrea, CALIFORNIA (USA)
The right results, the first time, in your mid-volume laboratory. Streamline workflow and maximize staff walkaway time with the DxH 690T hematology analyzer. This 5-part differential CBC analyzer helps you give your patients rapid results, while enabling your technologists to simplify processes and reduce manual tasks. The benchtop system includes the same automated ...
Manufactured by:Agappe Diagnostics Switzerland GmbH based inCham, SWITZERLAND
Global Haematology automation is growing rapidly and compact 5-Part Hematology analyser is the need of the hour for small and mid-sized laboratory.BC-5140 is especially tailored to assist diagnostic labs who need full CBC + 5-part differential results, with relatively low daily sample load As the lightest and most compact 5-part hematology analyzer, BC-5140 is a ...
Manufactured by:Agappe Diagnostics Switzerland GmbH based inCham, SWITZERLAND
Mispa Count X with Smart Impedance Technology, is an advanced 3-part differential cell counter which offers quality CBC testing to deliver safe patient care. Mispa Count X is a cost effective hematology solution tailored for different environments: routine laboratories, satellite labs, and emergency care unit. This advanced 3-part differential automated ...
Manufactured by:Agappe Diagnostics Switzerland GmbH based inCham, SWITZERLAND
Mispa Count X Plus is a quantitative Auto Hematology Analyzer and 3-part differential counter for in Vitro Diagnostic Use in clinical laboratories. The purpose of this analyzer is to identify the normal patient, with all normal system-generated parameters, and to flag or identify patient ...
Manufactured by:Beckman Coulter, Inc. based inBrea, CALIFORNIA (USA)
Designed for higher-volume laboratories, Beckman Coulter’s DxH 800 goes beyond cell counting to focus on each individual cell’s size, shape and internal structure. By employing Automated Intelligent Morphology (AIM), this enhanced multi-dimensional high-definition cellular analysis solution utilizes flow cytometric technology to deliver results to physicians and patients ...
Manufactured by:Beckman Coulter, Inc. based inBrea, CALIFORNIA (USA)
Developed with the mid- to large-volume clinical hematology laboratory in mind, the UniCel DxH 600 employs Automated Intelligent Morphology (AIM), an enhanced multi-dimensional high-definition cellular analysis solution that utilities flow cytometric technology. With AIM, your laboratory can count on first-pass accuracy of results to help you deliver accurate and efficient ...
by:Stemline Therapeutics, Inc. based inNew York, NEW YORK (USA)
SL-801 is a structurally novel, oral, small molecule, reversible inhibitor of exportin-1 (XPO1), a nuclear transport protein implicated in both solid tumors and hematologic malignancies. SL-801 has demonstrated preclinical in vitro and in vivo antitumor activity against a wide array of solid and hematologic cancers. SL-801’s potential ability to reversibly ...
by:Stemline Therapeutics, Inc. based inNew York, NEW YORK (USA)
In addition to expression on tumor bulk, CD123 expression has been reported on the cancer stem cells (CSCs), of certain hematologic cancers including AML, CML, MDS, and potentially T-cell ALL. In addition, elevated CD123 expression has been correlated with poor prognosis in certain hematologic ...
by:Stemline Therapeutics, Inc. based inNew York, NEW YORK (USA)
Inhibition of XPO1 has been shown to restore tumor suppressor function and proper cell cycle regulation, leading to apoptosis of cancer cells. XPO1 has also been shown to be a clinically validated target in both solid and hematological cancers. SL-801 has demonstrated broad and SL-801 has demonstrated broad and potent preclinical activity in a wide array of solid and ...
Manufactured by:Precision For Medicine, Inc. based inFrederick, MARYLAND (USA)
Advancing your research into hematological malignancies, immunology, and other related areas requires access to high quality human bone marrow mononuclear cells. Precision for Medicine has an extensive inventory of normal, healthy donors with longitudinal data and ability to recall for additional biospecimen ...
by:CDR-Life based inSchlieren, SWITZERLAND
CDR-Life’s T cell engaging antibodies are potentially transformative in the field of cancer immunotherapies» Prof. Markus G. Manz, MD, Head of Medical Oncology and Hematology at University Hospital and University of Zurich, Switzerland. CDR-Life’s pipeline is based on it’s unique antibody fragment platform. It includes a series of highly cancer-targeted ...
Manufactured by:Octapharma AG based inLachen, SWITZERLAND
Plasma-derived human factor IX ...
Manufactured by:Octapharma AG based inLachen, SWITZERLAND
Contains von Willebrand factor and factor VIII in a 1:1 activity ratio. Indication: Indicated for the prevention and treatment of haemorrhage or surgical bleeding in von Willebrand disease (VWD), when desmopressin (DDAVP) alone is ineffective or contra-indicated, and for the treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII ...
Manufactured by:Octapharma AG based inLachen, SWITZERLAND
Human coagulation factor VIII produced in a human cell line by recombinant DNA technology. No animal or human derived materials are added during the manufacturing process or to the final medicinal product. ...
Manufactured by:Prima Lab SA based inBalerna, SWITZERLAND
COVID-19 Neutralising IgG Serological Test is a rapid device which verifies the presence of COVID-19 neutralising IgG antibodies in human blood samples produced after the end of the vaccination cycle. ...